Nutritional treatment of atopic diseases according to YouTube videos

Simon Høj; Hanieh Meteran; Simon Francis Thomsen; Torben Sigsgaard; Howraman Meteran

doi:10.1016/j.jaip.2023.01.055

Nutritional treatment of atopic diseases according to YouTube videos

Simon Høj, Hanieh Meteran, Simon Francis Thomsen, Torben Sigsgaard, Howraman Meteran^*

^*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

4 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Journal of Allergy and Clinical Immunology: In Practice
Vol/bind	11
Udgave nummer	5
Sider (fra-til)	1552-1553
ISSN	2213-2198
DOI	https://doi.org/10.1016/j.jaip.2023.01.055
Status	Udgivet - 2023

Bibliografisk note

Funding Information:
Conflicts of interest: Ha. Meteran reports receiving honoraria for lectures and advisory board meetings from GlaxoSmithKline, Teva, Novartis, Sanofi-Aventis, Airsonett AB, and ALK-Abelló not related to this study within the past 5 years. Ho. Meteran has received a research grant from ALK-Abelló A/S outside this study. Outside the study, S. F. Thomsen has been a speaker and/or advisor for Sanofi , AbbVie , LEO Pharma, Pfizer , Eli Lilly, Novartis , UCB Pharma , Almirall, Union Therapeutics, and Janssen Pharmaceuticals and has received research support from Sanofi , AbbVie , LEO Pharma, Novartis , UCB Pharma , and Janssen Pharmaceuticals . The rest of the authors declare that they have no relevant conflicts of interest.

Adgang til dokumentet

10.1016/j.jaip.2023.01.055

Citationsformater

@article{816e72a4ec45458c8b2c4c5ae7294752,

title = "Nutritional treatment of atopic diseases according to YouTube videos",

author = "Simon H{\o}j and Hanieh Meteran and Thomsen, {Simon Francis} and Torben Sigsgaard and Howraman Meteran",

note = "Funding Information: Conflicts of interest: Ha. Meteran reports receiving honoraria for lectures and advisory board meetings from GlaxoSmithKline, Teva, Novartis, Sanofi-Aventis, Airsonett AB, and ALK-Abell{\'o} not related to this study within the past 5 years. Ho. Meteran has received a research grant from ALK-Abell{\'o} A/S outside this study. Outside the study, S. F. Thomsen has been a speaker and/or advisor for Sanofi , AbbVie , LEO Pharma, Pfizer , Eli Lilly, Novartis , UCB Pharma , Almirall, Union Therapeutics, and Janssen Pharmaceuticals and has received research support from Sanofi , AbbVie , LEO Pharma, Novartis , UCB Pharma , and Janssen Pharmaceuticals . The rest of the authors declare that they have no relevant conflicts of interest. ",

year = "2023",

doi = "10.1016/j.jaip.2023.01.055",

language = "English",

volume = "11",

pages = "1552--1553",

journal = "The Journal of Allergy and Clinical Immunology: In Practice",

issn = "2213-2198",

publisher = "Elsevier",

number = "5",

}

TY - JOUR

T1 - Nutritional treatment of atopic diseases according to YouTube videos

AU - Høj, Simon

AU - Meteran, Hanieh

AU - Thomsen, Simon Francis

AU - Sigsgaard, Torben

AU - Meteran, Howraman

N1 - Funding Information: Conflicts of interest: Ha. Meteran reports receiving honoraria for lectures and advisory board meetings from GlaxoSmithKline, Teva, Novartis, Sanofi-Aventis, Airsonett AB, and ALK-Abelló not related to this study within the past 5 years. Ho. Meteran has received a research grant from ALK-Abelló A/S outside this study. Outside the study, S. F. Thomsen has been a speaker and/or advisor for Sanofi , AbbVie , LEO Pharma, Pfizer , Eli Lilly, Novartis , UCB Pharma , Almirall, Union Therapeutics, and Janssen Pharmaceuticals and has received research support from Sanofi , AbbVie , LEO Pharma, Novartis , UCB Pharma , and Janssen Pharmaceuticals . The rest of the authors declare that they have no relevant conflicts of interest.

PY - 2023

Y1 - 2023

U2 - 10.1016/j.jaip.2023.01.055

DO - 10.1016/j.jaip.2023.01.055

M3 - Comment/debate

C2 - 36863613

AN - SCOPUS:85151951260

VL - 11

SP - 1552

EP - 1553

JO - The Journal of Allergy and Clinical Immunology: In Practice

JF - The Journal of Allergy and Clinical Immunology: In Practice

SN - 2213-2198

IS - 5

ER -